Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?

Andrew Worster, Samuel M. Keim, Rajiv Vadera, Peter Rosen

Research output: Contribution to journalArticle

Abstract

Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM - Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.

Original languageEnglish (US)
Pages (from-to)479-483
Number of pages5
JournalJournal of Emergency Medicine
Volume34
Issue number4
DOIs
StatePublished - May 1 2008

Keywords

  • EBM
  • clopidogrel
  • drug therapy
  • myocardial infarction
  • platelet aggregation inhibitors

ASJC Scopus subject areas

  • Emergency Medicine

Fingerprint Dive into the research topics of 'Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?'. Together they form a unique fingerprint.

  • Cite this